News Shortcuts from other journals

Candidate malaria vaccine looks safe and potentially effective

BMJ 2007; 335 doi: (Published 25 October 2007) Cite this as: BMJ 2007;335:851

International efforts to control malaria include developing and testing new vaccines directed against the pre-erythrocytic stage of Plasmodium falciparum. RTS,S/AS02D, a candidate manufactured by GlaxoSmithKline, has reached the stage of preliminary testing in humans, and early results look promising

View Full Text

Log in

Log in through your institution


* For online subscription